99 related articles for article (PubMed ID: 8443784)
1. Expression of plasminogen activator and plasminogen activator inhibitor by rat mesothelioma induced by asbestos.
Lenz SP; Green FH; Murphy PG; Lee M; Hart DA
Cancer Lett; 1993 Feb; 68(2-3):119-27. PubMed ID: 8443784
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors.
Heidtmann HH; Hofmann M; Jacob E; Erbil C; Havemann K; Schwartz-Albiez R
Cancer Res; 1989 Dec; 49(24 Pt 1):6960-5. PubMed ID: 2555056
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plasminogen activator inhibitors.
Pelayo BA; Fu YM; Meadows GG
Clin Exp Metastasis; 1999; 17(10):841-8. PubMed ID: 11089882
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activators and plasminogen activator inhibitors in connective tissues and connective tissue cells: influence of the neuropeptide substance P on expression.
Murphy PG; Hart DA
Biochim Biophys Acta; 1993 Sep; 1182(2):205-14. PubMed ID: 7689342
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of plasminogen activator and plasminogen activator inhibitor by osteotropic factors in primary cultures of mature osteoblasts and osteoblast precursors.
Pfeilschifter J; Erdmann J; Schmidt W; Naumann A; Minne HW; Ziegler R
Endocrinology; 1990 Feb; 126(2):703-11. PubMed ID: 2298166
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
7. Effect of retinoic acid on human neuroblastoma: correlation between morphological differentiation and changes in plasminogen activator and inhibitor activity.
Benjamin LA; McGarry RC; Hart DA
Cancer Chemother Pharmacol; 1989; 25(1):25-31. PubMed ID: 2590998
[TBL] [Abstract][Full Text] [Related]
8. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
Takeuchi T; Niiya K; Kubonishi I; Miyoshi I
Thromb Haemost; 1990 Apr; 63(2):259-64. PubMed ID: 2363126
[TBL] [Abstract][Full Text] [Related]
9. Decreased tissue plasminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine.
Pelayo BA; Fu YM; Meadows GG
Int J Oncol; 2001 Apr; 18(4):877-83. PubMed ID: 11251188
[TBL] [Abstract][Full Text] [Related]
10. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase.
Gross TJ; Simon RH; Kelly CJ; Sitrin RG
Am J Physiol; 1991 Apr; 260(4 Pt 1):L286-95. PubMed ID: 1902065
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
[TBL] [Abstract][Full Text] [Related]
12. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator system in human breast cancer.
Sumiyoshi K; Serizawa K; Urano T; Takada Y; Takada A; Baba S
Int J Cancer; 1992 Feb; 50(3):345-8. PubMed ID: 1735602
[TBL] [Abstract][Full Text] [Related]
14. Human HuH-7 hepatoma cells express urokinase and plasminogen activator inhibitor-1: identification, characterization and regulation by inflammatory mediators.
Arndt A; Murphy P; Hart DA
Biochim Biophys Acta; 1992 Feb; 1138(2):149-56. PubMed ID: 1371701
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type I and tissue-type plasminogen activator in the rat ovary during gonadotropin-induced ovulation.
Liu YX; Peng XR; Ny T
Eur J Biochem; 1991 Jan; 195(2):549-55. PubMed ID: 1900052
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy.
Estellés A; Gilabert J; Andrés C; España F; Aznar J
Thromb Haemost; 1990 Oct; 64(2):281-5. PubMed ID: 2125378
[TBL] [Abstract][Full Text] [Related]
17. Changes in and partial identification of the plasminogen activator and plasminogen activator inhibitor systems during ovarian follicular maturation in the pig.
Politis I; Srikandakumar A; Turner JD; Tsang BK; Ainsworth L; Downey BR
Biol Reprod; 1990 Oct; 43(4):636-42. PubMed ID: 2149659
[TBL] [Abstract][Full Text] [Related]
18. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
19. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
[TBL] [Abstract][Full Text] [Related]
20. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]